Literature DB >> 7464557

Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.

W R Hazzard, G R Warnick, G Utermann, J J Albers.   

Abstract

The largest reported kindred of a proband with type III hyperlipoproteinemia was investigated by assessment of lipid and lipoprotein levels and very low density lipoprotein (VLDL) isoapolipoprotein E distributions in all accessible family members (56% of the 124 living blood relatives and 59% of the 37 spouses). The results confirm in this kindred a trimodal distribution of apoE3/E2 ratios, and segregation analysis of 16 informative matings classified according to E3/E2 ratio demonstrated classical Mendelian inheritance of the autosomal codominant type: the E3/E2 ratio is determined by two alleles, apoE3d and apoE3n, which produce three phenotypes apoE3-D, apoE3-ND, and apoE3-N, corresponding to the low, intermediate, and high modes, respectively. Vertical transmission of the apoE3-D phenotype occurred in two branches of the second generation. In both instances this represented pseudodominance; i.e., products of heterozygous (apoE3-ND) x homozygous (apoE3-D) matings. Hyperlipidemia (defined as a low density lipoprotein cholesterol and/or plasma triglyceride level exceeding the respective age-, sex-, and sex-steroid-specific 95th percentiles derived from Lipid Research Clinics population studies) was present in 15 blood relatives in multiple lipoprotein patterns, consistent with the presence of familial combined hyperlipidemia in this kindred. Eight of nine members with the apoE3-D phenotype had either type III hyperlipoproteinemia or, in the absence of hyperlipidemia, beta-VLDL and at least marginally cholesterol-rich VLDL (VLDL-cholesterol/plasma triglyceride greater than 0.25) (defined as dysbetalipoproteinemia). The ninth such member, the only child with this phenotype, was normal. beta-VLDL and marginally cholesterol-rich VLDL was seen in but one of six hyperlipidemic family members of phenotype apoE3-ND, in none of seven hyperlipidemic blood relatives of phenotype apoE3-N, in no normolipidemic family members of phenotype apoE3-ND or apoE3-N, and in no spouses (three of whom were hyperlipidemic and nine of phenotype apoE3-ND). Thus, among adult members of the O'D kindred the apo3-D phenotype was nearly specifically associated with dysbetalipoproteinemia or, when hyperlipidemia was present, type III hyperlipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7464557     DOI: 10.1016/0026-0495(81)90223-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Plasma and lipoprotein lipid responses to four hypolipid drugs.

Authors:  W R Hazzard; P W Wahl; C Gagne; D Applebaum-Bowden; G R Warnick; J J Albers
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

Review 2.  Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

Authors:  M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

3.  Apolipoprotein E phenotypes and hyperlipidemia.

Authors:  G Utermann; I Kindermann; H Kaffarnik; A Steinmetz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis.

Authors:  G Utermann; A Steinmetz; W Weber
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

5.  Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.

Authors:  M R Wardell; S O Brennan; E D Janus; R Fraser; R W Carrell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

6.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

Authors:  K H Weisgraber; S C Rall; T L Innerarity; R W Mahley; T Kuusi; C Ehnholm
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia.

Authors:  E C Klasen; P J Talmud; L Havekes; E de Wit; E van der Kooij-Meijs; M Smit; G Hansson; S E Humphries
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

9.  Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.

Authors:  R W Milne; P K Weech; L Blanchette; J Davignon; P Alaupovic; Y L Marcel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.